GE HealthCare (NASDAQ: GEHC) reported Q1 EPS of $0.99, $0.06 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $5.03 billion.

For the full-year 2026, guidance is as follows:

• Organic revenue growth* of 3.0% to 4.0% year-over-year; unchanged
• Adjusted EBIT margin* of 15.4% to 15.7%, reflecting an expansion of 10 bps to 40 bps year-over-year; this compares to previous Adjusted EBIT margin* guidance of 15.8% to 16.1%
• Adjusted effective tax rate (ETR)* in the range of 20.0% to 21.0%; unchanged
• Adjusted EPS* in the range of $4.80 to $5.00, representing 4.6% to 9.0% growth year-over-year; this compares to previous Adjusted EPS* guidance in the range of $4.95 to $5.15
• Free cash flow* of approximately $1.6 billion, in-line with profit outlook; this compares to previous guidance of approximately $1.7 billion

For earnings history and earnings-related data on GE HealthCare (GEHC) click here.